Advertisement

Topics

Trial starts for compound that could be game-changer in malaria elimination

08:38 EDT 21 Aug 2017 | thePharmaLetter

Swiss pharma giant Novartis and Medicines for Malaria Venture, a not-for-profit public-private partnership,…

Original Article: Trial starts for compound that could be game-changer in malaria elimination

NEXT ARTICLE

More From BioPortfolio on "Trial starts for compound that could be game-changer in malaria elimination"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...